• PYR-41: Inhibitor of Ubiquitin-Activating Enzyme E1 for Adva

  2026-07-27

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect ubiquitin-proteasome system inhibition and NF-κB pathway modulation in intricate disease models. This article links mechanistic insights from cancer immunology to practical workflows and troubleshooting, enabling translational teams to drive impactful discoveries.

• Vernakalant Hydrochloride Enables Rapid Pharmacological Conv

  2026-07-26

  The referenced phase 3 trial demonstrates that vernakalant hydrochloride achieves rapid and effective conversion of recent-onset atrial fibrillation (AF) to sinus rhythm, outperforming placebo and providing a viable alternative to electrical cardioversion. The study’s robust design and stratification by AF duration offer new insights into targeted antiarrhythmic therapy with improved safety and efficiency.

• Molecular Mechanisms of TRPM3 Modulation by Neurosteroids an

  2026-07-25

  Yin et al. provide high-resolution cryo-EM structures of the mouse TRPM3 channel in complex with neurosteroids and the anticonvulsant primidone. Their work clarifies the molecular basis of TRPM3 gating, inhibition, and disease mutation effects, supporting rational drug development for pain and neurodevelopmental disorders.

• Gentamycin Sulfate: Mechanistic Foundations and Research Uti

  2026-07-24

  Gentamycin Sulfate is a benchmark aminoglycoside antibiotic for bacterial protein synthesis research, with well-characterized mechanisms and robust in vitro efficacy against Gram-negative pathogens. Its action at the 30S ribosomal subunit is central to studies of antibiotic resistance and ribosome function. This dossier consolidates protocol parameters, evidentiary claims, and practical limits for advanced laboratory application.

• Murine RNase Inhibitor: Precision RNA Degradation Prevention

  2026-07-24

  Murine RNase Inhibitor from APExBIO delivers oxidation-resistant, targeted RNA protection for sensitive workflows like real-time RT-PCR and cDNA synthesis. Its enhanced stability under low-reducing conditions enables robust performance where conventional RNase A inhibitors fall short, giving researchers a reliable edge in preserving RNA integrity.

• Digoxin in Translational Research: Mechanisms, Models, and I

  2026-07-23

  This thought-leadership article explores Digoxin’s dual role as a Na+/K+ ATPase pump inhibitor in cardiovascular and antiviral research, providing mechanistic insight, validated protocol guidance, and strategic vision for translational scientists. Drawing on recent evidence and cross-domain experience, it outlines how precise application of Digoxin (SKU B7684, APExBIO) can drive advances in heart failure, arrhythmia, and chikungunya virus research—while highlighting the importance of rigorous vendor selection and workflow optimization.

• CRTC-CREB Axis as a Sensor of Proteotoxic Stress in Drosophi

  2026-07-23

  This study demonstrates that proteasome inhibitors, including MLN2238, activate the CRTC-CREB transcriptional axis in Drosophila, linking proteasome inhibition to cellular stress adaptation. The findings reveal a conserved ROS/JNK-mediated pathway that modulates CREB activity, highlighting potential strategies for studying proteotoxic stress and neurodegenerative disease mechanisms.

• Structural Basis of TRPM3 Regulation by Neurosteroids and Dr

  2026-07-22

  Yin et al. provide high-resolution cryo-EM structures of the TRPM3 ion channel in complex with neurosteroids and the anticonvulsant primidone, mapping specific ligand binding sites and elucidating gating mechanisms. These insights clarify how neurosteroids and inhibitors modulate TRPM3 activity, advancing the rationale for targeted therapeutics in pain and TRPM3-linked neurodevelopmental disorders.

• AP1903: FKBP-Binding Ligand for Conditional Cell Ablation Wo

  2026-07-22

  AP1903 enables nanomolar-precision control of FKBP fusion proteins, unlocking rapid, tunable apoptosis and cell ablation in advanced research models. Its compatibility with multiplexed assays and robust in vivo performance sets a new benchmark for controlled protein activation workflows.

• Sulfachloropyridazine in Microbial Ecology: Protocols & Insi

  2026-07-21

  Sulfachloropyridazine, a potent sulfonamide antibacterial agent, is redefining experimental workflows in microbial ecology and infection models. Its precision as a DHPS inhibitor enables advanced enzyme inhibition assays, microbiome modulation, and integrative metabolomics, offering researchers unparalleled control and reproducibility.

• Peptidisc-Assisted Nanobody Multimerization: A Protein Engin

  2026-07-21

  Chen and Duong van Hoa introduce a peptidisc-based method for stabilizing hydrophobic clustering to generate multimeric and multispecific nanobody proteins. This approach enhances nanobody affinity and functional diversity, representing a significant methodological advance for the production and application of engineered protein assemblies.

• RNA Pol II Inhibition Triggers Apoptosis via Active Signalin

  2026-07-20

  Harper et al. reveal that cell death from RNA Pol II inhibition is not a passive consequence of mRNA decay, but a regulated apoptotic response initiated by loss of hypophosphorylated RNA Pol IIA. This mechanistic insight reframes how transcriptional machinery impacts apoptosis, with implications for cancer therapy development and apoptosis research.

• Suhuang Capsule Suppresses ER Stress and NLRP3 in Cough Vari

  2026-07-20

  This study demonstrates that Suhuang antitussive capsule ameliorates pulmonary dysfunction in a cough variant asthma model by suppressing endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. The work advances mechanistic understanding of inflammation-driven pulmonary disease and reveals ER stress as a central pharmacological target.

• Sulfachloropyridazine: Mechanistic Insights and Innovation i

  2026-07-19

  Explore how Sulfachloropyridazine, a broad-spectrum sulfonamide antibacterial agent, enables advanced mechanistic studies of microbial enzyme inhibition and resistance. This article goes beyond microbiota modulation, offering unique protocol guidance and critical analysis for researchers optimizing antimicrobial assays.

• Sulfamonomethoxine: Applied Protocols and Environmental Insi

  2026-07-18

  Sulfamonomethoxine (SMM) stands out as a versatile veterinary and aquaculture antibiotic, offering robust protocols for bacterial and protozoal control. This guide provides hands-on workflow enhancements, troubleshooting strategies, and actionable insights on environmental biotransformation, arming researchers and practitioners with credible, data-backed solutions.

450 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page